A marriage of formal methods and LLMs seeks to harness the strengths of both.

I'm sorry NixOS, I've failed you.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

A few stanzas from the end of Chaucer’s long poem “Troilus and Criseyde,” the author interrupts his story to indulge in a bit of reception anxiety. “Go, litel book,” he bids the manuscript that’s soon ...

AI insiders and outsiders are both feeling helpless about the same thing.

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Halo Infinite remains to be on the top of gamers' minds despite all the reworks and delays the game has gone through. Although Xbox and developer 343 Industries have shown a few trailers and little ...